- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/08 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Patent holdings for IPC class C07D 413/08
Total number of patents in this class: 187
10-year publication summary
|
10
|
9
|
12
|
37
|
14
|
15
|
6
|
13
|
16
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 172 |
32 |
| Bristol-myers Squibb Company | 4893 |
8 |
| Janssen Pharmaceutica N.V. | 3383 |
6 |
| Assembly Biosciences, Inc. | 77 |
6 |
| Takeda Pharmaceutical Company Limited | 2709 |
5 |
| Cytokinetics, Inc. | 277 |
5 |
| Merck Sharp & Dohme LLC | 3741 |
5 |
| Boehringer Ingelheim International GmbH | 4648 |
4 |
| Epizyme, Inc. | 370 |
4 |
| Isosterix, Inc. | 7 |
4 |
| Katholieke Universiteit Leuven | 1190 |
3 |
| Novartis AG | 10850 |
2 |
| F. Hoffmann-La Roche AG | 7921 |
2 |
| Genentech, Inc. | 3980 |
2 |
| Merck Patent GmbH | 5823 |
2 |
| Amgen Inc. | 4044 |
2 |
| Sumitomo Chemical Company, Limited | 9047 |
2 |
| Board of Regents, The University of Texas System | 5803 |
2 |
| Vertex Pharmaceuticals Incorporated | 1595 |
2 |
| CHDI Foundation, Inc. | 108 |
2 |
| Other owners | 87 |